Overactive Bladder - Results from #1560

#ICS2014 - Poster: Clinical and quality of life outcomes in male non‐neurogenic overactive bladder managed with intra‐detrusor botulinum toxin type A: An 8 year experience October 28, 2014

#ICS2014 - Poster: Multicenter analysis of 10 years follow up after repeat intravesical botulinum toxin-A injections in patients with detrusor overactivity October 28, 2014

Association of urinary urgency and delay time of micturition in women with overactive bladder - Abstract October 27, 2014

Clinical outcome in male patients with detrusor overactivity with impaired contractility - Abstract October 25, 2014

Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism - Abstract October 23, 2014

Overactive bladder: OTC oxybutynin transdermal patch for women - Abstract October 23, 2014

#ICS2014 - Poster: Repeat onabotulinumtoxinA treatment in spinal cord injury patients with neurogenic detrusor overactivity: Final analysis of 4 years’ follow-up confirms sustained safety and efficacy October 22, 2014

#ICS2014 - Poster: A cost-effectiveness analysis of onabotulinumtoxinA for overactive bladder in patients inadequately managed with anticholinergic medications in Spain October 22, 2014

#ICS2014 - Poster: OnabotulinumtoxinA demonstrates similar improvements in urinary incontinence and quality of life regardless of the use of clean intermittent catheterization or the presence of urinary tract infection in patients with overactive bladder October 22, 2014

A randomized controlled study to evaluate the efficacy of tamsulosin monotherapy and its combination with mirabegron on patients with overactive bladder induced by benign prostatic obstruction - Abstract October 21, 2014

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: Two case reports - Abstract October 17, 2014

The overactive bladder progression to underactive bladder hypothesis - Abstract October 16, 2014

Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects - Abstract October 15, 2014

Onabotulinum toxin A: A therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder - Abstract October 14, 2014

The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy - Abstract October 10, 2014

Sacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: A cost-utility analysis in the perspective of Italian Healthcare System - Abstract October 9, 2014

Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations - Abstract October 8, 2014

Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: A randomized controlled trial - Abstract October 7, 2014

Practice Guidelines: AUA releases guideline on diagnosis and treatment of overactive bladder October 7, 2014

Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly - Abstract October 7, 2014

Page 79 of 122